Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Potiga

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    A drug from resin to combat epileptic seizures
    A drug from resin to combat epileptic seizures

    08 Jun 2021

    // SCIENCEDAILY

    https://www.sciencedaily.com/releases/2021/06/210608113220.htm#:~:text=One%20drug%2C%20retigabine%2C%20can%20open,the%20bladder%20and%20blood%20vessels.

    SCIENCEDAILY
    08 Jun 2021
    Share Share
    Knopp Biosciences Presents +ve Preclinical Data for Lead Neonatal Epilepsy Drug
    Knopp Biosciences Presents +ve Preclinical Data for Lead Neonatal Epilepsy Drug

    24 May 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190524005151/en/Knopp-Biosciences-Presents-Positive-Preclinical-Data-Lead/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    24 May 2019
    Share Share
    Xenon adds discontinued GlaxoSmithKline drug ezogabine to epilepsy pipeline
    Xenon adds discontinued GlaxoSmithKline drug ezogabine to epilepsy pipeline

    06 Sep 2018

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/xenon-adds-discontinued-gsk-med-to-epilepsy-pipeline

    Amirah Al Idrus FIERCE BIOTECH
    06 Sep 2018
    Share Share
    GSK to supply US with Ventolin from French plant production halt at Zebulon
    GSK to supply US with Ventolin from French plant production halt at Zebulon

    22 Dec 2015

    // Gareth MacDonald+ IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Drug-Delivery/GSK-to-supply-US-with-Ventolin-from-French-plant-after-production-halt-at-Zebulon

    Gareth MacDonald+ IN PHARMATECHNOLOGIST
    22 Dec 2015
    Share Share
    SciFluor Receives US Patent for KCNQ2/3 Activator to Treat Epilepsy and Neurological Disorders
    SciFluor Receives US Patent for KCNQ2/3 Activator to Treat Epilepsy and Neurological Disorders

    12 Jan 2015

    // Press Release SCIFLUOR LIFE SCIENCES

    http://www.scifluor.com/media-center/docs/SciFluor_SF0034_USPatent_PR.pdf

    Press Release SCIFLUOR LIFE SCIENCES
    12 Jan 2015
    Share Share